2023 was a troublesome yr for that biopharma sector, with many firms downsizing and restructuring their workforces to remain afloat. You'll find indications of Restoration, as mergers and acquisitions picked up through the pharmaceutical and existence sciences industry in the latter Element of 2023 and also have ongoing their upswing https://sites.google.com/view/bio-sites/blog